With OK From FDA, UC San Diego Researchers Prepare to Launch Novel Phage Study
Health & BehaviorFDA approves first U.S. clinical trial of an intravenously administered bacteriophage-based therapy to treat resistant bacterial infections.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.